Clinical trial
Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
NCT01057121
Study timeline
Study start (actual)2010-08-27Date precision: day
Registry last updated2022-02-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
AIDS-Related Kaposi Sarcomaunresolved
Recurrent Kaposi Sarcomaunresolved
Interventions
LenalidomideDRUG · verified · RxNorm: lenalidomide
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
SeattleWashington, United States2New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1MiamiFlorida, United States1San FranciscoCalifornia, United States1San DiegoCalifornia, United States1ColumbusOhio, United States1HonoluluHawaii, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01057121 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.